Related Experiment Video

Updated: Jul 6, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

Community-acquired bacterial pneumonia in children: an update on antibiotic duration and immunization strategies

Edward Lyon1, Liset Olarte2

  • 1Department of Pediatrics, Division of Infectious Diseases, Children's Mercy Kansas City.

Current Opinion in Pediatrics
|January 3, 2024
PubMed

Insights

Short antibiotic courses (3-5 days) are effective for uncomplicated pediatric bacterial pneumonia. Newer vaccines and allergy de-labeling strategies are crucial for preventing severe respiratory infections in children.

Area of Science:

  • Pediatric infectious diseases
  • Respiratory medicine
  • Clinical microbiology

Background:

  • Pediatric bacterial pneumonia remains a significant cause of childhood illness and death globally.
  • Current treatment guidelines for antibiotic therapy duration vary between high-income and low-income countries.
  • Accurate penicillin allergy assessment is critical for appropriate pneumonia management in children.

Approach:

  • This review synthesizes current evidence on the epidemiology, antibiotic treatment, and prevention of pediatric bacterial pneumonia.
  • It examines recent randomized controlled trials on antibiotic course length for uncomplicated cases.
  • The review also covers updated immunization recommendations and allergy de-labeling strategies.

Key Points:

  • Evidence supports a 3-5 day antibiotic course for uncomplicated pediatric bacterial pneumonia in outpatient settings.
  • Prompt penicillin allergy de-labeling is essential to avoid suboptimal treatment.
  • Newer pneumococcal vaccines are expected to reduce the incidence of pneumococcal pneumonia.

Conclusions:

  • Short-course antibiotic therapy is likely sufficient for outpatient management of uncomplicated bacterial pneumonia.
  • Further research is needed to confirm optimal inpatient treatment durations.
  • The impact of novel pneumococcal and RSV vaccines on pneumonia epidemiology requires ongoing investigation.
Abstract

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.7K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.5K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
239
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
231
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
279